New frontiers in selective human MAO-B inhibitors: miniperspective

S Carradori, R Silvestri - Journal of medicinal chemistry, 2015 - ACS Publications
Accumulating evidence shows a relationship between the human MAO-B (hMAO-B) enzyme
and neuropsychiatric/degenerative disorder, personality traits, type II alcoholism, borderline …

Inhibitor design for monoamine oxidases

R R. Ramsay - Current pharmaceutical design, 2013 - benthamdirect.com
Flavin-containing monoamine oxidases (MAO A and MAO B) located on the outer
membrane of mitochondria oxidise amines and generate hydrogen peroxide. Inhibitors …

New pyrazoline bearing 4 (3H)-quinazolinone inhibitors of monoamine oxidase: Synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B …

N Gökhan-Kelekçi, S Koyunoğlu, S Yabanoğlu… - Bioorganic & medicinal …, 2009 - Elsevier
A new series of pyrazoline derivatives were prepared starting from a quinazolinone ring and
evaluated for antidepressant, anxiogenic and MAO-A and-B inhibitory activities by in vivo …

MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains

ÖD Can, D Osmaniye, ÜD Özkay, BN Sağlık… - European journal of …, 2017 - Elsevier
In the present work, 15 new N'-(arylidene)-4-(1-(prop-2-yn-1-yl)-1H-benzo [d] imidazol-2-yl)
benzohydrazide (4a-4o) were designed and synthesized. The structures of the synthesized …

Design, Synthesis, and In Vitro and In Silico Approaches of Novel Indanone Derivatives as Multifunctional Anti-Alzheimer Agents

BN Sağlık, S Levent, D Osmaniye, AE Evren… - ACS …, 2022 - ACS Publications
Alzheimer's disease (AD) is a neurological, progressive illness that typically affects the
elderly and is clinically distinguished by memory and cognitive decline. Due to a number of …

Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b

TG Marshall, RE Lee, FE Marshall - Theoretical Biology and Medical …, 2006 - Springer
Background There have been indications that common Angiotensin Receptor Blockers
(ARBs) may be exerting anti-inflammatory actions by directly modulating the immune …

In vitro and in silico evaluation of new thiazole compounds as monoamine oxidase inhibitors

BN Sağlık, BK Çavuşoğlu, D Osmaniye, S Levent… - Bioorganic …, 2019 - Elsevier
New twenty compounds bearing thiazole ring (3a-3t) were designed and synthesized as
monoamine oxidase (MAO) inhibitors. The fluorometric enzyme inhibition assay was used to …

Monoamine oxidase inhibitors: ten years of docking studies

G Ferino, S Vilar, MJ Matos, E Uriarte… - Current topics in …, 2012 - ingentaconnect.com
The number of papers dealing with the structure-based drug design is continuously growing,
which demonstrates the importance of such tools in medicinal chemistry. In the current …

Design, synthesis and biological assessment of new thiazolylhydrazine derivatives as selective and reversible hMAO-A inhibitors

NÖ Can, D Osmaniye, S Levent, BN Sağlık… - European journal of …, 2018 - Elsevier
In the recent works, it was shown that numerous thiazolylhydrazine derivatives display h
MAO inhibitory activity in the range of micromolar concentration. Hence, in the present study …

Computational insight into the mechanism of the irreversible inhibition of monoamine oxidase enzymes by the antiparkinsonian propargylamine inhibitors rasagiline …

T Tandarić, R Vianello - ACS Chemical Neuroscience, 2019 - ACS Publications
Monoamine oxidases (MAOs) are flavin adenine dinucleotide containing flavoenzymes that
catalyze the degradation of a range of brain neurotransmitters, whose imbalance is …